Atovacuona Glenmark

Atovaquone is an oral medication used to treat and prevent certain parasitic infections. It is commonly prescribed for conditions like malaria and PCP. This medication is manufactured by Glenmark Arzneimittel Gmbh.

Atovaquone is primarily used to treat and prevent parasitic infections, including malaria and Pneumocystis pneumonia (PCP). It works by stopping the growth of parasites in the body. This medication is often prescribed for individuals who are at risk of these infections, such as those with weakened immune systems.

Common effects of Atovaquone may include nausea, vomiting, diarrhea, and stomach pain. Some users may also experience headache, dizziness, or fever. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Atovaquone should be used with caution in individuals with liver or kidney problems. It is important to follow the prescribed dosage and not to exceed it. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking.

Atovaquone may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking this medication.